Prognostic Value of VEGF in Patients Submitted to Percutaneous Coronary Intervention
We examined the longitudinal changes of VEGF levels after percutaneous coronary intervention for predicting major adverse cardiac events (MACE) in coronary artery disease (CAD) patients. VEGF was measured in 94 CAD patients’ serum before revascularization, 1-month and 1-year after. Independently of...
Main Authors: | Catarina Ramos, Patrícia Napoleão, Mafalda Selas, Cláudia Freixo, Ana Maria Viegas Crespo, Miguel Mota Carmo, Rui Cruz Ferreira, Teresa Pinheiro |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2014/135357 |
Similar Items
-
Clinical-epidemiological aspects of patients submitted to Percutaneous Coronary Intervention in a university hospital
by: Maria Solange Moreira de Lima, et al. -
Evaluation of the impact of chronic kidney disease on the survival of octogenarian patients submitted to percutaneous coronary intervention
by: Julio Cesar Queiroz de Franca, et al.
Published: (2018-11-01) -
The Proinflammatory Soluble CD40 Ligand Is Associated with the Systemic Extent of Stable Atherosclerosis
by: Tiago Pereira-da-Silva, et al.
Published: (2021-01-01) -
Incidence, predictors and prognostic implications of bleeding complicating primary percutaneous coronary intervention
by: Matić Dragan M., et al.
Published: (2015-01-01) -
Inflammation during Percutaneous Coronary Intervention—Prognostic Value, Mechanisms and Therapeutic Targets
by: Bradley Tucker, et al.
Published: (2021-06-01)